Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic.
Al-Riyami AZ, Burnouf T, Wood EM, Devine DV, Oreh A, Apelseth TO, Goel R, Bloch EM, van Den Berg K, Getshen M, Louw V, Ang AL, Lee CK, Rahimi-Levene N, Stramer SL, Vassallo R, Schulze TJ, Patidar GK, Pandey HC, Dubey R, Badawi M, Hindawi S, Meshi A, Matsushita T, Sorrentino E, Grubovic Rastvorceva RM, Bazin R, Vermeulen M, Nahirniak S, Tsang HC, Vrielink H, Triyono T, Addas-Carvalho M, Hećimović A, Torres OW, Mutindu SM, Bengtsson J, Dominguez D, Sayedahmed A, Hanisa Musa R, Gautam B, Herczenik E, So-Osman C; ISBT COVID-19 Convalescent Plasma Working Group. Al-Riyami AZ, et al. Among authors: vrielink h. Vox Sang. 2022 Jun;117(6):822-830. doi: 10.1111/vox.13256. Epub 2022 Mar 8. Vox Sang. 2022. PMID: 35262978 Free PMC article.
Editor's bio: Dr. Hans Vrielink.
Vrielink H. Vrielink H. Transfus Apher Sci. 2023 Apr;62(2):103663. doi: 10.1016/j.transci.2023.103663. Epub 2023 Feb 24. Transfus Apher Sci. 2023. PMID: 36872124 No abstract available.
Evaluation of a new HTLV-I/II polymerase chain reaction.
Vrielink H, Zaaijer HL, Cuypers HT, van der Poel CL, Woerdeman M, Lelie PN, Winkel C, Reesink HW. Vrielink H, et al. Vox Sang. 1997;72(3):144-7. doi: 10.1046/j.1423-0410.1997.7230144.x. Vox Sang. 1997. PMID: 9145484
Donor selection: the exclusion of high risk donors?
van den Burg PJ, Vrielink H, Reesink HW. van den Burg PJ, et al. Among authors: vrielink h. Vox Sang. 1998;74 Suppl 2:499-502. doi: 10.1111/j.1423-0410.1998.tb05464.x. Vox Sang. 1998. PMID: 9704489 Review.
Comparison of four HTLV-I and HTLV-I + II ELISAs.
Vrielink H, Reesink H, Habibuw M, Schuller M, van der Meer C, Lelie P. Vrielink H, et al. Vox Sang. 1999;76(3):187-91. doi: 10.1159/000031047. Vox Sang. 1999. PMID: 10341336
Collection of heparinized plasma by plasmapheresis.
van Der Meer PF, Vrielink H, Pietersz RN, Dekker WJ, Reesink HW. van Der Meer PF, et al. Among authors: vrielink h. Vox Sang. 1999;77(3):137-42. doi: 10.1159/000031092. Vox Sang. 1999. PMID: 10545849
Prevalence of leucocyte antibodies in the Dutch donor population.
Middelburg RA, Porcelijn L, Lardy N, Briët E, Vrielink H. Middelburg RA, et al. Among authors: vrielink h. Vox Sang. 2011 Apr;100(3):327-35. doi: 10.1111/j.1423-0410.2010.01420.x. Epub 2010 Oct 15. Vox Sang. 2011. PMID: 20946548
94 results